ID26335A - Metoda untuk mencegah restenosis dengan menggunakan tokotrienol - Google Patents
Metoda untuk mencegah restenosis dengan menggunakan tokotrienolInfo
- Publication number
- ID26335A ID26335A IDW20001179A ID20001179A ID26335A ID 26335 A ID26335 A ID 26335A ID W20001179 A IDW20001179 A ID W20001179A ID 20001179 A ID20001179 A ID 20001179A ID 26335 A ID26335 A ID 26335A
- Authority
- ID
- Indonesia
- Prior art keywords
- tokotrienol
- preventing restenosis
- restenosis
- preventing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US97170397A | 1997-11-17 | 1997-11-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
ID26335A true ID26335A (id) | 2000-12-14 |
Family
ID=25518699
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IDW20001179A ID26335A (id) | 1997-11-17 | 1998-11-17 | Metoda untuk mencegah restenosis dengan menggunakan tokotrienol |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1037628A4 (id) |
JP (1) | JP2001522880A (id) |
AU (1) | AU746369B2 (id) |
CA (1) | CA2310232A1 (id) |
ID (1) | ID26335A (id) |
WO (1) | WO1999025336A1 (id) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE470442T1 (de) * | 2000-03-31 | 2010-06-15 | Eisai R&D Man Co Ltd | Verwendung von gamma-tocotrienol als diuretika |
US7713546B1 (en) * | 2001-04-03 | 2010-05-11 | Soft Gel Technologies, Inc. | Corosolic acid formulation and its application for weight-loss management and blood sugar balance |
DE10115740A1 (de) | 2001-03-26 | 2002-10-02 | Ulrich Speck | Zubereitung für die Restenoseprophylaxe |
CA2484383C (en) | 2002-07-12 | 2016-05-31 | Cook Incorporated | Medical device coated with a bioactive agent |
DE10244847A1 (de) | 2002-09-20 | 2004-04-01 | Ulrich Prof. Dr. Speck | Medizinische Vorrichtung zur Arzneimittelabgabe |
US8101199B2 (en) | 2003-10-21 | 2012-01-24 | Celonova Biosciences, Inc. | Des-methyl-tocopherol therapy for restenosis prevention |
EP1811935B1 (en) | 2004-09-28 | 2016-03-30 | Atrium Medical Corporation | Heat cured gel and method of making |
US20060088596A1 (en) | 2004-09-28 | 2006-04-27 | Atrium Medical Corporation | Solubilizing a drug for use in a coating |
US9012506B2 (en) | 2004-09-28 | 2015-04-21 | Atrium Medical Corporation | Cross-linked fatty acid-based biomaterials |
US9801982B2 (en) | 2004-09-28 | 2017-10-31 | Atrium Medical Corporation | Implantable barrier device |
US9000040B2 (en) | 2004-09-28 | 2015-04-07 | Atrium Medical Corporation | Cross-linked fatty acid-based biomaterials |
EP2471530B1 (en) | 2005-06-01 | 2017-01-11 | Edison Pharmaceuticals, Inc. | Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers |
US9427423B2 (en) | 2009-03-10 | 2016-08-30 | Atrium Medical Corporation | Fatty-acid based particles |
US9278161B2 (en) | 2005-09-28 | 2016-03-08 | Atrium Medical Corporation | Tissue-separating fatty acid adhesion barrier |
AU2006304590A1 (en) | 2005-10-15 | 2007-04-26 | Atrium Medical Corporation | Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings |
JP5374162B2 (ja) | 2006-02-22 | 2013-12-25 | エジソン ファーマシューティカルズ, インコーポレイテッド | ミトコンドリア病および他の症状の処置のためのレドックス活性化治療の側鎖変異体およびエネルギーバイオマーカーの調節 |
EP2626091B1 (en) | 2006-11-06 | 2016-09-28 | Atrium Medical Corporation | Coated surgical mesh |
US9492596B2 (en) | 2006-11-06 | 2016-11-15 | Atrium Medical Corporation | Barrier layer with underlying medical device and one or more reinforcing support structures |
US9192697B2 (en) | 2007-07-03 | 2015-11-24 | Hemoteq Ag | Balloon catheter for treating stenosis of body passages and for preventing threatening restenosis |
CA2736250C (en) | 2008-09-10 | 2016-12-20 | Edison Pharmaceuticals, Inc. | Treatment of pervasive developmental disorders with redox-active therapeutics |
WO2011005421A2 (en) | 2009-07-10 | 2011-01-13 | Boston Scientific Scimed, Inc. | Use of nanocrystals for a drug delivery balloon |
JP5933434B2 (ja) | 2009-07-17 | 2016-06-08 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | 薬剤送達バルーンの製造方法 |
US20110038910A1 (en) | 2009-08-11 | 2011-02-17 | Atrium Medical Corporation | Anti-infective antimicrobial-containing biomaterials |
HUE037592T2 (hu) | 2009-08-26 | 2018-09-28 | Bioelectron Tech Corp | Eljárások cerebrális ischemia megelõzésére és kezelésére |
EP2593141B1 (en) | 2010-07-16 | 2018-07-04 | Atrium Medical Corporation | Composition and methods for altering the rate of hydrolysis of cured oil-based materials |
US8889211B2 (en) | 2010-09-02 | 2014-11-18 | Boston Scientific Scimed, Inc. | Coating process for drug delivery balloons using heat-induced rewrap memory |
US9056152B2 (en) | 2011-08-25 | 2015-06-16 | Boston Scientific Scimed, Inc. | Medical device with crystalline drug coating |
US9867880B2 (en) | 2012-06-13 | 2018-01-16 | Atrium Medical Corporation | Cured oil-hydrogel biomaterial compositions for controlled drug delivery |
WO2014014517A1 (en) * | 2012-07-19 | 2014-01-23 | The Ohio State University | Method of ameliorating clotting pathologies and related materials and methods |
CN113024369A (zh) | 2015-12-17 | 2021-06-25 | Ptc医疗公司 | 用于治疗氧化应急障碍的化合物 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0543417A1 (en) * | 1991-11-22 | 1993-05-26 | Lipogenics, Incorporated | Tocotrienols and tocotrienol-like compounds and methods for their use |
DE4333794A1 (de) * | 1993-10-04 | 1995-04-06 | Carl Heinrich Dr Weischer | Neue Acetyl-Salicylsäure-Derivate zur Bekämpfung von Entzündungs- und Schmerzzuständen sowie zur Thromboseprophylaxe und -terapie |
EP0669132A1 (en) * | 1994-02-23 | 1995-08-30 | van der Kraaij, Antonius Marinus Maria | Pharmaceutical composition of vitamin E and acetylsalicylate for treatment and prevention of atherosclerosis |
-
1998
- 1998-11-17 CA CA002310232A patent/CA2310232A1/en not_active Abandoned
- 1998-11-17 EP EP98960259A patent/EP1037628A4/en not_active Withdrawn
- 1998-11-17 AU AU15902/99A patent/AU746369B2/en not_active Ceased
- 1998-11-17 JP JP2000520770A patent/JP2001522880A/ja active Pending
- 1998-11-17 WO PCT/US1998/024606 patent/WO1999025336A1/en not_active Application Discontinuation
- 1998-11-17 ID IDW20001179A patent/ID26335A/id unknown
Also Published As
Publication number | Publication date |
---|---|
EP1037628A1 (en) | 2000-09-27 |
EP1037628A4 (en) | 2002-08-21 |
JP2001522880A (ja) | 2001-11-20 |
CA2310232A1 (en) | 1999-05-27 |
AU746369B2 (en) | 2002-04-18 |
AU1590299A (en) | 1999-06-07 |
WO1999025336A1 (en) | 1999-05-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ID26335A (id) | Metoda untuk mencegah restenosis dengan menggunakan tokotrienol | |
IS8368A (is) | Ný aðferð | |
FI102426B1 (fi) | Menetelmä muistin toteuttamiseksi | |
DE69830295D1 (de) | Steuerungsverfahren | |
FI102424B1 (fi) | Menetelmä muistin toteuttamiseksi | |
ATE260243T1 (de) | N-aroylphenylalaninderivate | |
EE03801B1 (xx) | Stent | |
FI971620A (fi) | Autentikointimenetelmä | |
DK0958287T3 (da) | Sulfamidmetalloprotease-inhibitorer | |
FI102425B1 (fi) | Menetelmä muistin toteuttamiseksi | |
ID19075A (id) | Perangkap tempat kaustik untuk asetaldehida | |
DE69815975D1 (de) | Steuerungsverfahren | |
IS5106A (is) | Ný aðferð | |
DE69816734D1 (de) | Steuerungsverfahren | |
NO20003079D0 (no) | Polymerisasjon-oppstartningsprosess | |
ATE292632T1 (de) | Cis-disubstituierte aminocycloalkyl-pyrrolidin- derivate | |
DE69708229T2 (de) | Muster-Herstellungsverfahren | |
NO20003080D0 (no) | Polymerisasjon-oppstartningsprosess | |
FI974067A0 (fi) | Process foer cellulasbehandling | |
DE29711942U1 (de) | Einrichtung zum Bearbeiten | |
DE29713277U1 (de) | Bohnenstangen-Set | |
FI102961B (fi) | Menetelmä tuhkan käsittelemiseksi | |
ID21138A (id) | Teknologi film-tipis untuk head-drum | |
FI970906A0 (fi) | Säätelymenetelmä | |
ID19172A (id) | Metoda penstabilan |